All
Results: 34633-34644 of 47677

Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)

Consumer Packaged Goods Leader Church & Dwight Selects Rockwell Automation to Increase Manufacturing Cybersecurity Resilience
